NVTA Description — Invitae Corp
Invitae is engaged in the business of delivering genetic testing services, digital health solutions and health data services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. Testing and other services are delivered via a platform that serves patients, healthcare providers, biopharma companies and other partners. Co. applies proprietary design, process automation, robotics and bioinformatics software solutions to achieve efficiencies in sample processing and complex variant interpretation, allowing medical interpretation at scale.
|
Free NVTA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Sell (1.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts Forecast: NVTA Price Target Based on data provided by Zacks Investment Research via Quandl.com |